EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study
| Autor: | Zauderer, Marjorie G *, Szlosarek, Peter W, Le Moulec, Sylvestre, Popat, Sanjay, Taylor, Paul, Planchard, David, Scherpereel, Arnaud, Koczywas, Marianna, Forster, Martin, Cameron, Robert B, Peikert, Tobias, Argon, Evren Kocabaş, Michaud, Neil R, Szanto, Attila, Yang, Jay, Chen, Yingxue, Kansra, Vikram, Agarwal, Shefali, Fennell, Dean A ** |
|---|---|
| Zdroj: | In The Lancet Oncology June 2022 23(6):758-767 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|